Molecular pathology findings that are related to lymphomagenesis may be used as diagnostic tools, in conjunction with conventional methods. In particular, the use of genetic lesions as diagnostic markers of non-Hodgkin's lymphomas is supported by the selective association of certain genetic alterations with specific histological entities
For the past 20 years most malignant lymphomas have been classified as clinicopathological entities,...
We review the problem of lymphoma classification in the light of the Revised European-American Lymph...
Available from British Library Document Supply Centre- DSC:DXN060426 / BLDSC - British Library Docum...
Molecular pathology findings that are related to lymphomagenesis may be used as diagnostic tools, in...
Despite a common origin from mature lymphoid cells, non-Hodgkin lymphomas (NHL) represent a surprisi...
Non-Hodgkin lymphomas (NHL), the 6th most frequent cancer in western countries, represent a large gr...
Lymphomas encompass a diverse group of malignant lymphoid neoplasms. Over recent years much scientif...
Recent advances in immunology, cytogenetics and molecular genetics has allowed for a better understa...
Accurate diagnosis in lymphoproliferative diseases results from a combination of investigations: his...
The wide clinicopathologic heterogeneity of non-Hodgkin's lymphoma is reflected by the various molec...
In recent years, DNA-arrays, gene expression profiling and next-generation sequencing have elucidate...
The surface of mononuclear cells obtained from heparinized peripheral blood from 18 patients with no...
descrizione di tecniche innovative per la diagnostica differenziale dei linfomi non HOdgkin
Malignant lymphoproliferative disorders include highly heterogeneous entities, i.e. lymphomas (Non-H...
For the past 20 years most malignant lymphomas have been classified as clinicopathological entities,...
For the past 20 years most malignant lymphomas have been classified as clinicopathological entities,...
We review the problem of lymphoma classification in the light of the Revised European-American Lymph...
Available from British Library Document Supply Centre- DSC:DXN060426 / BLDSC - British Library Docum...
Molecular pathology findings that are related to lymphomagenesis may be used as diagnostic tools, in...
Despite a common origin from mature lymphoid cells, non-Hodgkin lymphomas (NHL) represent a surprisi...
Non-Hodgkin lymphomas (NHL), the 6th most frequent cancer in western countries, represent a large gr...
Lymphomas encompass a diverse group of malignant lymphoid neoplasms. Over recent years much scientif...
Recent advances in immunology, cytogenetics and molecular genetics has allowed for a better understa...
Accurate diagnosis in lymphoproliferative diseases results from a combination of investigations: his...
The wide clinicopathologic heterogeneity of non-Hodgkin's lymphoma is reflected by the various molec...
In recent years, DNA-arrays, gene expression profiling and next-generation sequencing have elucidate...
The surface of mononuclear cells obtained from heparinized peripheral blood from 18 patients with no...
descrizione di tecniche innovative per la diagnostica differenziale dei linfomi non HOdgkin
Malignant lymphoproliferative disorders include highly heterogeneous entities, i.e. lymphomas (Non-H...
For the past 20 years most malignant lymphomas have been classified as clinicopathological entities,...
For the past 20 years most malignant lymphomas have been classified as clinicopathological entities,...
We review the problem of lymphoma classification in the light of the Revised European-American Lymph...
Available from British Library Document Supply Centre- DSC:DXN060426 / BLDSC - British Library Docum...